Yuyu Pharma, Inc. (KRX: 000220)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,235.00
+75.00 (1.80%)
Nov 18, 2024, 3:30 PM KST

Yuyu Pharma Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Operating Revenue
135,281137,210138,881115,65598,12090,878
Upgrade
Other Revenue
-0-0-0-0-
Upgrade
Revenue
135,281137,210138,881115,65598,12090,878
Upgrade
Revenue Growth (YoY)
-1.54%-1.20%20.08%17.87%7.97%9.36%
Upgrade
Cost of Revenue
86,00888,68285,91570,56752,96544,409
Upgrade
Gross Profit
49,27248,52752,96645,08845,15546,469
Upgrade
Selling, General & Admin
35,87837,97243,02837,27032,46436,071
Upgrade
Research & Development
2,9877,1888,6204,0084,123876.67
Upgrade
Other Operating Expenses
217.06219.22221.25258.87196.61214.61
Upgrade
Operating Expenses
42,30249,27653,55943,88838,88438,394
Upgrade
Operating Income
6,970-748.94-592.111,2006,2718,075
Upgrade
Interest Expense
-2,689-2,554-2,581-2,175-1,759-1,787
Upgrade
Interest & Investment Income
1,024990.69605.88216.83210.32398.97
Upgrade
Earnings From Equity Investments
-493.69-493.69395.07548.18286.22360.65
Upgrade
Currency Exchange Gain (Loss)
-215.8-23.86-478.1256.72-198.24402.8
Upgrade
Other Non Operating Income (Expenses)
-1,833-2,592-852.87-87.18-1,217-1,491
Upgrade
EBT Excluding Unusual Items
2,762-5,422-3,503-240.683,5935,960
Upgrade
Gain (Loss) on Sale of Investments
1,506657.78182.69-139.24-110.356.74
Upgrade
Gain (Loss) on Sale of Assets
1,130-98.3-46.08-3.23282.15633.6
Upgrade
Asset Writedown
-499.39-579.76-444.09--53.65-
Upgrade
Pretax Income
4,899-5,442-3,810-383.163,7116,600
Upgrade
Income Tax Expense
116.4198.44615.02537.131,2991,037
Upgrade
Earnings From Continuing Operations
4,783-5,541-4,425-920.292,4135,563
Upgrade
Minority Interest in Earnings
-2,182-1,640-1,562-1,294-1,129-841.05
Upgrade
Net Income
2,600-7,181-5,988-2,2141,2844,722
Upgrade
Preferred Dividends & Other Adjustments
873.7325.9284.89284.89284.89284.89
Upgrade
Net Income to Common
1,726-7,207-6,273-2,499998.634,437
Upgrade
Net Income Growth
-----72.82%17.46%
Upgrade
Shares Outstanding (Basic)
171617161212
Upgrade
Shares Outstanding (Diluted)
171617161215
Upgrade
Shares Change (YoY)
5.80%-1.89%3.90%32.81%-19.87%0.14%
Upgrade
EPS (Basic)
104.17-443.01-378.31-156.5783.10377.83
Upgrade
EPS (Diluted)
104.17-443.01-378.31-157.0083.00376.31
Upgrade
EPS Growth
-----77.94%33.66%
Upgrade
Free Cash Flow
11,898-4,094-11,512-1,565-14,7165,129
Upgrade
Free Cash Flow Per Share
701.15-251.63-694.28-98.04-1224.65342.01
Upgrade
Gross Margin
36.42%35.37%38.14%38.98%46.02%51.13%
Upgrade
Operating Margin
5.15%-0.55%-0.43%1.04%6.39%8.89%
Upgrade
Profit Margin
1.28%-5.25%-4.52%-2.16%1.02%4.88%
Upgrade
Free Cash Flow Margin
8.80%-2.98%-8.29%-1.35%-15.00%5.64%
Upgrade
EBITDA
12,6644,8584,4355,70310,17011,195
Upgrade
EBITDA Margin
9.36%3.54%3.19%4.93%10.37%12.32%
Upgrade
D&A For EBITDA
5,6945,6075,0274,5033,8993,121
Upgrade
EBIT
6,970-748.94-592.111,2006,2718,075
Upgrade
EBIT Margin
5.15%-0.55%-0.43%1.04%6.39%8.89%
Upgrade
Effective Tax Rate
2.38%---34.99%15.71%
Upgrade
Advertising Expenses
-4,4817,1196,1314,3825,711
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.